Faculty Appointments
Patient Care Setting
Cancer
Biography
When a patient is diagnosed with cancer, he or she is faced with a lot of questions and uncertainty of what the future holds. My philosophy is to provide as much information as possible so that patients can make the best decisions for themselves and their families and so that together we can face any fears or worries head on.
I chose this field because my hope is to make the lives of cancer patients better – whether it is through direct patient care or my research, which focuses on pancreatobiliary cancers, as well as weight loss and muscle wasting related to cancer.
In addition to being passionate about cancer care, I have many interests outside of work that I enjoy sharing with my patients such as sports, travel and music.
Conditions I Treat
- Esophageal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer
- Colorectal cancer
- Anal cancer
Credentials
Education
2009
MD | SUNY Downstate Health Sciences University - College of Medicine
2021
MS | University of Rochester
Post-doctoral Training & Residency
07/01/2016 - 06/30/2019
Fellowship at University of Rochester Medical Center
07/01/2013 - 06/30/2015
Fellowship in Hematology & Oncology at University of Rochester Medical Center
06/25/2010 - 06/24/2012
Residency in Internal Medicine at University of Rochester Medical Center
06/25/2009 - 06/24/2010
Internship in Internal Medicine at University of Rochester Medical Center
VIEW ALL expand_more
Awards
2022 - 2027
Cancer Grand Challenges: Understand and Reverse Cachexia
Sponsor: National Cancer Institute and Cancer Research UK
2020 - 2021
Solid Tumor Faculty Leader in clinical trial accrual
Location: Wilmot Cancer Institute
2019 - 2021
CTSI KL2 Career Development Award
Location: University of Rochester Medical Center
2017 - 2018
Department of Medicine Research Pilot Grant Award
2016 - 2019
NIH R25 Fellowship Training Program in Cancer Control
Location: University of Rochester Medical Center
2015 - 2018
Wilmot Foundation for Cancer Research Fellowship Award
VIEW ALL expand_more
Clinical Trials
A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma,A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma
Lead Researcher: Richard F Dunne
The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuvant or adjuvant treatment.
View Study Details
An Open-label Phase 1 Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lead Researcher: Richard F Dunne
The main purpose of this research study is to determine the maximum tolerable dose (MTD) of SX-682 in combination with nivolumab in patients with metastatic pancreatic ductal adenocarcinoma who have completed at least 16 weeks of first line chemotherapy treatment without evidence of disease progression.
View Study Details
Publications
Journal Articles
4/27/2023
Ferrer M, Anthony TG, Ayres JS, Biffi G, Brown JC, Caan BJ, Cespedes Feliciano EM, Coll AP, Dunne RF, Goncalves MD, Grethlein J, Heymsfield SB, Hui S, Jamal-Hanjani M, Lam JM, Lewis DY, McCandlish D, Mustian KM, O'Rahilly S, Perrimon N, White EP, Janowitz T. "Cachexia: A systemic consequence of progressive, unresolved disease." Cell.. 2023 Apr 27; 186(9):1824-1845.
2/2023
Lin PJ, Altman BJ, Gilmore NJ, Loh KP, Dunne RF, Bautista J, Fung C, Janelsins MC, Peppone LJ, Melnik MK, Gococo KO, Messino MJ, Mustian KM. "Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors." Journal of the National Comprehensive Cancer Network : JNCCN.. 2023 Feb; 21(2):153-162.e2.
12/22/2022
Melucci AD, Lynch OF, Loria A, Mustian KM, Dunne RF, Temple LK, Fleming FJ. "A Novel Use for Pelvic Magnetic Resonance Imaging Scans to Estimate Lean Body Mass and Screen for Sarcopenia in Patients with Rectal Cancer." Diseases of the colon and rectum.. 2022 Dec 22; Epub 2022 Dec 22.
VIEW ALL PUBLICATIONS